DePoortere David, Kofonow Jennifer M, Chen Bei, Chiu Alexander G, Cohen Noam A
University of Pennsylvania School of Medicine Department of Otorhinolaryngology, Philadelphia, Pennsylvania, USA.
Otolaryngol Head Neck Surg. 2011 Sep;145(3):482-8. doi: 10.1177/0194599811399558.
Determine the toxicity and efficacy of a novel antiprotease topical irrigation, polyhydrated ionogen (PHI) ± MgBr2, in improving sinonasal remucosalization following surgery.
Blinded, randomized controlled study. Setting. Academic.
Ciliary beat frequency (CBF) of murine nasal septal explants was continuously recorded before and after addition of PHI solution to asses for ciliotoxicity. To evaluate for efficacy in remucosalization, 9 New Zealand white rabbits underwent bilateral medial-wall maxillary mucosal stripping followed by placement of an indwelling irrigation catheter. In a randomized fashion one side received 3 mL of normal saline (NS) daily, whereas the contralateral side received PHI ± MgBr2. Following a 14-day therapeutic trial, remucosalization was assessed by hematoxylin and eosin staining and immunohistochemistry for β-tubulin, a marker of cilia. A semiquantitative grading of ciliated remucosalization was applied with a chi-square test to compare the saline with the PHI ± MgBr2 treatment.
Safety evaluation of the PHI solutions demonstrated no evidence of ciliotoxicity. Histologic semiquantitative analysis of maxillary sinus remucosalization demonstrated significantly more ciliated epithelium (>60%) in the majority of PHI (n = 4) and PHI with MgBr2 (n = 5) treatment compared with the saline treatment (<30%) (n = 9). This was confirmed with immunohistochemical staining for type IV β-tubulin a marker of respiratory cilia.
Success of functional endoscopic sinus surgery depends on restoration of normal mucociliary clearance. Topical PHI application has previously been demonstrated to significantly increase dermal wound healing. PHI solution is not ciliotoxic, and daily topical PHI or PHI MgBr2 irrigation enhances ciliated remucosalization compared with saline.
确定一种新型抗蛋白酶局部冲洗剂多水离子原(PHI)±溴化镁在改善鼻窦手术后黏膜再形成方面的毒性和疗效。
双盲、随机对照研究。研究地点:学术机构。
在添加PHI溶液前后,连续记录小鼠鼻中隔外植体的纤毛摆动频率(CBF),以评估其对纤毛的毒性。为评估其在黏膜再形成方面的疗效,9只新西兰白兔接受双侧上颌内侧壁黏膜剥离术,随后放置留置冲洗导管。以随机方式,一侧每天接受3 mL生理盐水(NS)冲洗,而对侧接受PHI±溴化镁冲洗。经过14天的治疗试验后,通过苏木精-伊红染色和免疫组织化学检测β-微管蛋白(一种纤毛标记物)来评估黏膜再形成情况。应用纤毛黏膜再形成的半定量分级,采用卡方检验比较生理盐水冲洗与PHI±溴化镁冲洗的效果。
PHI溶液的安全性评估显示没有纤毛毒性的证据。上颌窦黏膜再形成的组织学半定量分析表明,与生理盐水冲洗组(<30%,n = 9)相比,大多数接受PHI冲洗组(n = 4)和PHI加溴化镁冲洗组(n = 5)中有更多的纤毛上皮(>60%)。这通过对IV型β-微管蛋白(一种呼吸纤毛标记物)的免疫组织化学染色得到证实。
功能性鼻内镜鼻窦手术的成功取决于正常黏液纤毛清除功能的恢复。此前已证明局部应用PHI可显著促进皮肤伤口愈合。PHI溶液无纤毛毒性,与生理盐水相比,每日局部应用PHI或PHI加溴化镁冲洗可增强纤毛黏膜再形成。